This consultation closed on 5 September 2023
Consultation period8 August 2023 to 5 September 2023
The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of a new active constituent, tigolaner, and registration of the products, Felpreva Spot-On for Cats (3 sizes: 1.0 to 2.5 kg, 2.5 to 5 kg, and 5 to 8 kg). Felpreva is a topical spot-on solution containing 97.90 mg/mL tigolaner (9.79% w/v), 81.4 mg/mL praziquantel (8.14% w/v), and 20.35 mg/mL emodepside (2.04% w/v). The products are for the treatment and prevention of flea infestations, control of ticks and mites; and treatment and control of intestinal worms in cats and kittens from 10 weeks of age.
We invite comments from 8 August 2023 to 5 September 2023 on whether approval of the active constituent and registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds, including:
- chemistry and manufacture
- occupational health and safety
- public health
- environmental safety
- efficacy and target animal safety.
For more information see page 16, APVMA Gazette No. 16, 8 August 2023.
Please note: submissions will be published on the APVMA’s website unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).
Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.
Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission and coversheet by email or post to:
Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Phone: +61 2 6770 2300